Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 11/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | F13A1 | P00488 | 4/20 | 0.34 |
| ▸ | TGM1 | P22735 | 4/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.33 |
| ▸ | BMX | P51813 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | TGM3 | Q08188 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28996992 | 0.94 | TGM2 (0.40) | TGM2MTNR1ABRD4F13A1TGM1 | |
| SCHEMBL26124919 | 0.94 | TGM2 (0.40) | TGM2MTNR1ABRD4F13A1TGM1 | |
| SCHEMBL28997075 | 0.80 | TGM2 (0.38) | TGM2MTNR1AF13A1TGM1TDP2 | |
| SCHEMBL28997061 | 0.79 | TGM2 (0.44) | TGM2MTNR1ABRD4F13A1TGM1 | |
| SCHEMBL28997071 | 0.77 | TGM2 (0.40) | TGM2MTNR1ABRD4F13A1TGM1 | |
| SCHEMBL26124319 | 0.76 | TGM2 (0.53) | TGM2TEAD1 | |
| SCHEMBL28997537 | 0.76 | TGM2 (0.53) | TGM2TEAD1 | |
| SCHEMBL28996914 | 0.76 | TGM2 (0.53) | TGM2TEAD1 | |
| SCHEMBL26332962 | 0.76 | TGM2 (0.38) | TGM2MTNR1ABRD4F13A1TGM1 | |
| SCHEMBL28997062 | 0.75 | TGM2 (0.39) | TGM2MTNR1AF13A1TGM1TDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116057042-B | Acrylamide-substituted indane compounds and their therapeutic uses | 赛诺菲 | 2024-10-18 | — | — | CN | claimed |
| CN-116057042-A | Acrylamide-substituted indane compounds and their therapeutic uses | 赛诺菲 | 2023-05-02 | — | — | CN | claimed |
| CN-116057042-B | Acrylamide-substituted indane compounds and their therapeutic uses | 赛诺菲 | 2024-10-18 | — | — | CN | disclosed |
| EP-4188907-A1 | ACRYLAMIDE-SUBSTITUTED INDANE COMPOUNDS AND THERAPEUTIC USE THEREOF | SANOFI (FR) | 2023-06-07 | — | — | EP | disclosed |
| CN-116057042-A | Acrylamide-substituted indane compounds and their therapeutic uses | 赛诺菲 | 2023-05-02 | — | — | CN | disclosed |
| WO-2022023460-A1 | ACRYLAMIDE-SUBSTITUTED INDANE COMPOUNDS AND THERAPEUTIC USE THEREOF | SANOFI (FR) | 2022-02-03 | — | — | WO | disclosed |